Clinical Trial Update: Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pembrolizumab in combination with neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Washington | Conditions: Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2025-09-18